Checkpoint Surgical
Series C in 2015
Checkpoint Surgical Inc., established in 2009 and headquartered in Cleveland, Ohio, specializes in manufacturing neuro devices for surgeons. Their primary products are CHECKPOINT 9094 and CHECKPOINT 9394, both designed to locate, identify, and evaluate motor nerve tissue and muscle function during complex surgical procedures. These devices cater to various applications such as head and neck surgeries, hand and extremities procedures, targeted muscle re-innervation, orthopedic oncology and trauma, and plastic reconstruction. The company sells its products through a network of distributors in the United States, aiming to enhance patient outcomes by providing surgeons with precise nerve stimulation and monitoring equipment.
SPR Therapeutics
Series A in 2013
SPR Therapeutics, LLC is a medical device company based in Cleveland, Ohio, specializing in the development and commercialization of interventional pain management therapies. The company focuses on peripheral nerve stimulation (PNS) systems, with its flagship product being the Smartpatch, a minimally invasive device designed to deliver short-term therapy for pain relief. This system is effective for various types of pain, including post-surgical discomfort following procedures like knee replacements and thoracotomies, as well as neuropathic and musculoskeletal pain. In addition to the Smartpatch, SPR Therapeutics offers the Micropulse, an implantable PNS system for long-term therapy, and the Smartpatch MicroLead, which promotes rapid tissue ingrowth. By providing non-narcotic alternatives for pain management, SPR Therapeutics aims to offer safe and effective treatments that reduce reliance on opioid medications and invasive surgeries. The company was founded in 2009 and has additional facilities in the Carolina’s Research Triangle and Minneapolis, Minnesota.
Deep Brain Innovations
Seed Round in 2012
Deep Brain Innovations is a medical device company that develops deep brain stimulation (DBS) systems for treating Parkinson's disease. Its DBS technology targets specific brain regions to relieve motor symptoms while reducing power consumption, potentially enabling smaller, longer-lasting implants and fewer surgical replacements. The company focuses on optimizing DBS therapy to improve efficiency and durability of implanted neurostimulation systems, helping clinicians deliver precise, energy-efficient brain stimulation. Founded in 2012 and based in Cleveland, Ohio, Deep Brain Innovations aims to provide effective, long-lasting DBS delivery that lowers patient risk and healthcare costs.
Checkpoint Surgical
Series B in 2012
Checkpoint Surgical Inc., established in 2009 and headquartered in Cleveland, Ohio, specializes in manufacturing neuro devices for surgeons. Their primary products are CHECKPOINT 9094 and CHECKPOINT 9394, both designed to locate, identify, and evaluate motor nerve tissue and muscle function during complex surgical procedures. These devices cater to various applications such as head and neck surgeries, hand and extremities procedures, targeted muscle re-innervation, orthopedic oncology and trauma, and plastic reconstruction. The company sells its products through a network of distributors in the United States, aiming to enhance patient outcomes by providing surgeons with precise nerve stimulation and monitoring equipment.